Myra Davis - 01 Oct 2026 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Reporting relationship: Director
Issuer ticker: USPH
Reported as of: 01 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Oct 2026, 16:09:34 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kate Venturina, as attorney-in-fact

Filing notes and source

Key filing fact

Myra Davis filed Form 4 for U S PHYSICAL THERAPY INC /NV (USPH) on 02 Oct 2026.

Key facts

This page summarizes Myra Davis's Form 4 filing for U S PHYSICAL THERAPY INC /NV (USPH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Oct 2026, 16:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002156047 Primary reporting owner

Davis Myra

Relationship: Director
Address: 1300 W SAM HOUSTON PKWAY S, SUITE 300, HOUSTON
Signature: /s/ Kate Venturina, as attorney-in-fact
Signature date: 02 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

USPH transaction

Common Stock

Award

Transaction value
Shares: +1,210
Change %
Price: $0.000000^*
Shares after: 1,210
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 1,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to the Reporting Person's continued service as a director through each applicable vesting date.